Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct 14:4:389-95.
doi: 10.2147/PPA.S8186.

Clinical utility and patient adherence with ebastine for allergic rhinitis

Giorgio Ciprandi  1
Affiliations

Clinical utility and patient adherence with ebastine for allergic rhinitis

Giorgio Ciprandi. Patient Prefer Adherence. .

Abstract

Allergic rhinitis (AR) is a high prevalence disease, affecting 10%-20% of the general population. AR is sustained by an IgE-mediated reaction, and by a complex inflammatory network of cells, mediators, and cytokines, becoming chronic when exposure to allergen persists. A Th2-biased immune response is the basis for the allergic inflammation. Histamine plays a relevant role in symptom occurrence. Therefore, antihistamine use represents a cornerstone in AR management. Ebastine, a novel antihistamine, is effective overall in controlling symptoms, and its safety profile is good. Recently, a new formulation has been developed, ie, a fast-dissolving tablet. Several studies have demonstrated its favorable characteristics. In conclusion, ebastine is an effective and well tolerated antihistamine that may be prescribed for the treatment of AR. The fast-dissolving tablet formulation provides a new option which may be particularly convenient for the patient.

Keywords: allergic rhinitis; antihistamines; ebastine; histamine; tablets.

PubMed Disclaimer

References

    1. Bousquet J, van de Cauwenberge P. Allergic Rhinitis and its Impact on Asthma (ARIA) WHO position paper. J Allergy Clin Immunol. 2001;108:S147–S334. - PubMed
    1. Bjorksten B, Brunekreef B, Cookson WO, von Mutius E, Strachan DP. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): Rationale and methods. Eur Respir J. 2004;24:406–412. - PubMed
    1. Bugiani A, Carosso A, Migliore E, et al. Allergic rhinitis and asthma comorbidity in a survey of young adults in Italy. Allergy. 2005;60:165–170. - PubMed
    1. Turkeltaub PC. Prevalence of upper and lower respiratory conditions in the US population by social and environmental factors: Data from the second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II) Ann Allergy. 1991;67:147–154. - PubMed
    1. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol. 2001;108:S45–S53. - PubMed